Eli Lilly stock dips after report flags China price cuts for Mounjaro
NEW YORK, December 30, 2025, 10:48 ET — Regular session
- Eli Lilly shares edged down about 0.2% in morning trading.
- A Reuters report said Lilly and Novo Nordisk are lowering obesity-drug prices in China, adding to global pricing scrutiny.
- An SEC filing showed Lilly Endowment Inc reported selling 2,629 shares in a recent transaction.
Eli Lilly and Company shares were down $1.73, or about 0.2%, at $1,077.00 in morning trading on Tuesday.
The move comes as investors focus on whether the weight-loss boom is entering a tougher phase on pricing, not just supply. Lilly’s obesity franchise has helped propel the stock, so any sign of discounting tends to land quickly with traders.
The issue matters now because competition is widening beyond the…
